Enovix (NASDAQ:ENVX) Shares Gap Down After Analyst Downgrade

Key Points

• JPMorgan downgrade sent Enovix shares sharply lower premarket — the stock gapped from a $6.88 close to a $6.35 open and last traded around $6.26 on volume of about 2.08 million shares.
• Analysts have been mixed: several firms trimmed target prices (e.g., Canaccord, Craig Hallum, B. Riley) while others reiterate buys or sells, leaving a consensus average rating of "Hold" with a $14.05 target.
• Fundamentals show a $1.36 billion market cap, negative P/E (-8.07), high liquidity (quick ratio 8.13, current ratio 8.34), 50.92% institutional ownership, and ongoing scaling of its silicon-anode battery manufacturing.

Enovix Corporation (NASDAQ:ENVX - Get Free Report)'s share price gapped down prior to trading on Wednesday after JPMorgan Chase & Co. downgraded the stock from a neutral rating to an underweight rating. The stock had previously closed at $6.88, but opened at $6.35. Enovix shares last traded at $6.2590, with a volume of 2,077,394 shares changing hands.

ENVX has been the subject of several other reports. Oppenheimer reiterated an "outperform" rating on shares of Enovix in a research note on Thursday, February 26th. Canaccord Genuity Group dropped their target price on Enovix from $21.00 to $15.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. Craig Hallum dropped their target price on Enovix from $16.00 to $10.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. B. Riley Financial dropped their target price on Enovix from $17.00 to $10.00 and set a "buy" rating for the company in a research note on Monday, March 2nd. Finally, Weiss Ratings reiterated a "sell (e+)" rating on shares of Enovix in a research note on Friday, April 10th. Six analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Enovix presently has an average rating of "Hold" and a consensus target price of $14.05.

Institutional Investors Weigh In On Enovix

Several institutional investors and hedge funds have recently added to or reduced their stakes in ENVX. Caitlin John LLC acquired a new stake in Enovix during the third quarter worth about $27,000. Caitong International Asset Management Co. Ltd acquired a new stake in Enovix during the fourth quarter worth about $30,000. Parallel Advisors LLC increased its stake in Enovix by 51.9% during the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company's stock worth $39,000 after acquiring an additional 1,342 shares during the last quarter. CWM LLC increased its stake in Enovix by 95.4% during the fourth quarter. CWM LLC now owns 6,081 shares of the company's stock worth $44,000 after acquiring an additional 2,969 shares during the last quarter. Finally, Calamos Advisors LLC acquired a new stake in Enovix during the first quarter worth about $60,000. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Enovix Price Performance

The company has a market capitalization of $1.36 billion, a price-to-earnings ratio of -8.07 and a beta of 2.24. The company has a quick ratio of 8.13, a current ratio of 8.34 and a debt-to-equity ratio of 1.90. The company has a 50 day simple moving average of $5.65 and a 200 day simple moving average of $7.36.

About Enovix

Enovix Corporation NASDAQ: ENVX develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.